| Drug Name: | Mirtazapine (61337-67-5) |
|---|---|
| PubChem ID: | 4205 |
| SMILES: | CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4 |
| InchiKey: | RONZAEMNMFQXRA-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Antidepressive Agents, Central Nervous System Agents, Histamine Agents, Histamine Antagonists, Histamine H1 Antagonists, Neurotransmitter Agents, Psychotropic Drugs |
| Molecular Weight (dalton) | : | 265.36 |
| LogP | : | 2.4789 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 19.37 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Linezolid (165800-03-3) | Confusion | Synergistic | Not fully understood | Linezolid: MAOI activity and potential drug interactions |
| Linezolid (165800-03-3) | Delirium | Synergistic | Not fully understood | Linezolid: MAOI activity and potential drug interactions |
| Linezolid (165800-03-3) | Serotonin Syndrome | Synergistic | Not fully understood | Linezolid: MAOI activity and potential drug interactions |
| Linezolid (165800-03-3) | Visual Hallucinations | Synergistic | Not fully understood | Linezolid: MAOI activity and potential drug interactions |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category